Charles Klucka
Allergy · Fort Myers, FLNPI 1043490055
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by GSK at 27.1% of the total. Reporting peaked in 2019 at $2,042 and has fallen 67.7% since, to $660 in 2022.
Across 188 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$907
- Sanofi$492
- Takeda Pharmaceuticals U.S.A., Inc.$263
- Kaleo, Inc.$263
- Genentech USA, Inc.$262
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,433100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 48 | $1,206 |
| AstraZeneca | 38 | $907 |
| Sanofi | 17 | $492 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $263 |
| Kaleo, Inc. | 14 | $263 |
| Genentech USA, Inc. | 7 | $262 |
| Regeneron Healthcare Solutions, Inc. | 10 | $232 |
| Novartis | 7 | $140 |
| CSL Behring | 5 | $128 |
| Pfizer | 5 | $114 |
| Alk-abello, Inc | 5 | $85 |
| Optinose US, Inc. | 5 | $78 |
| Mylan Specialty L.p. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Grifols USA, LLC | 2 | $36 |
| Pharming Healthcare, Inc. | 2 | $24 |
| Bio Products Laboratory USA, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Amgen | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
| Circassia Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$249
- NUCALA$233
- FASENRA$125
- DUPIXENT$110
How this compares
$4,442 in reported general payments places this provider in the 55th percentile of 56 allergy providers in Florida.
Other allergy in Fort Myers
- Donald SchwartzFort Myers$88
- Miguel LanzCoral Gables$778K
- Brett StanalandNaples$575K
- David RoseEglin Afb$253K
- Pavana BeerelliRockledge$61K
- Hugh WindomSarasota$37K
- Patrick de MarcoOrange Park$23K
- Mark MinorMelbourne$21K
- Alan KoterbaNorth Palm Beach$16K
- Brian WilsonTallahassee$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.